Hipertrigliceridemia, esteatosis hep谩tica y riesgo cardiovascular
详细信息查看全文 | 推荐本文 |
摘要

Objectives

Nonalcoholic fatty liver disease (NAFLD) has been associated with both hypertriglyceridemia and an increased risk of cardiovascular complications. The aim of our study was to assess factors related to the presence of NAFLD in patients with hypertriglyceridemia and to calculate their Framingham score risk.

Patients and methods

A total of 1.394 subjects (mean age 50.3 卤 12.4 years, 74.1%male) participating in the Hypertriglyceridemia Register of the Spanish Society of Arteriosclerosis were studied. Hypertriglyceridemia was considered as a triglyceride concentration 鈮?00 mg/dL confirmed on two different occasions. Liver steatosis was diagnosed by ultrasound. NAFLD was defined as the presence of steatosis in patients who were moderate alcohol consumers or abstainers.

Results

Of the 649 subjects included in the final sample, 321 (49.5%) had NAFLD. As expected, liver enzymes were higher in this population. The presence of NAFLD was associated with a higher body mass index (p < 0.001), increased waist circumference (p < 0.001) and a higher prevalence of metabolic syndrome (p < 0.001). No differences in triglyceride concentration or in the prevalence of diabetes were found between subjects with and without NAFLD. A Framingham risk score above 20%was observed in 52.4%of the participants, with no differences in relation to NAFLD status.

Conclusions

Hypertriglyceridemic subjects with NAFLD have a higher prevalence of obesity, mainly abdominal, and metabolic syndrome. The estimated cardiovascular risk in this population is very high but does not differ according to the presence of NAFLD.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700